Novo Nordisk Beat Expectations in Q4 and a Huge Catalyst Could Be Coming Soon
In the GLP-1 weight loss market, it's largely been a two-horse race between Eli Lilly and Novo Nordisk (NYSE: NVO). The two ...
Opinion
Hosted on MSN28mOpinion
Top Stock Reports for Apple, Eli Lilly & Shopify
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Eli Lilly and Co.
Eli Lilly & Co. stock underperforms Friday when compared to competitors
Shares of Eli Lilly & Co. LLY slid 3.00% to $844.27 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow ...
Ibj.com7h
Lebanon planning board to review designs for Lilly’s $4.5B foundry at LEAP District
The 200-acre Lilly Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers, including engineers, ...
FiercePharma10h
Fierce Pharma Asia—Astellas' investment focus; Mitsubishi Tanabe's buyout; Leqembi's 'expansion phase'
Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...
Lilly Gerrard the ‘luckiest’ as she shares Valentine's Day update
Lilly Gerrard was delighted as she shared her partner’s loving gesture on Valentine's Day. The daughter of Liverpool legend ...
Healio11h
VIVID-2: Omvoh demonstrates ‘continued durability,’ safety in Crohn’s disease at 2 years
Most patients with moderately to severely active Crohn’s disease who achieved endoscopic response and remission after 52 ...